| Product NDC: | 54569-4586 |
| Proprietary Name: | Clorazepate Dipotassium |
| Non Proprietary Name: | Clorazepate Dipotassium |
| Active Ingredient(s): | 15 mg/1 & nbsp; Clorazepate Dipotassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54569-4586 |
| Labeler Name: | A-S Medication Solutions LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075731 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000427 |
| Package NDC: | 54569-4586-1 |
| Package Description: | 12 TABLET in 1 BOTTLE (54569-4586-1) |
| NDC Code | 54569-4586-1 |
| Proprietary Name | Clorazepate Dipotassium |
| Package Description | 12 TABLET in 1 BOTTLE (54569-4586-1) |
| Product NDC | 54569-4586 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clorazepate Dipotassium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20000427 |
| Marketing Category Name | ANDA |
| Labeler Name | A-S Medication Solutions LLC |
| Substance Name | CLORAZEPATE DIPOTASSIUM |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |